Expert Cautious Over Global Fund’s New TB/HIV Funding Strategy, Devex Reports

“Groups advocating for [tuberculosis (TB)] elimination are hailing a new Global Fund proposed strategy that could raise coverage of the disease’s treatment, but an [unnamed] expert warns it entails some risks,” Devex reports. The recommendation — “that countries with high TB and HIV co-infection applying for Global Fund support only put forward a single, joint proposal for both diseases” — could “allow a country to tackle both diseases on the same level … and can lead to savings,” according to the expert, Devex states. However, the expert “said if the proposal is not properly implemented and not taken seriously, or some institutions and organizations resist it, there will be no progress in significantly scaling up TB and HIV services,” which “could lead to co-infected patients continuing to struggle to access care from two ‘vertical’ structures, as it is in many situations currently,” the news service writes. “The strategy is expected to be part of the Global Fund’s new funding model, which is scheduled for full implementation by March next year,” according to Devex (Ravelo, 11/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.